Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion type Assertion NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_head.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion description "[Estimates of effect for return to heavy drinking suggest it is possible that patients with at least one G allele of A118G polymorphism of OPRM1 might be more likely to respond to naltrexone, but confidence intervals were wide; additional studies are needed to improve confidence in the estimates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion evidence source_evidence_literature NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion SIO_000772 25410894 NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion wasDerivedFrom befree-2016 NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.
- NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_assertion wasGeneratedBy ECO_0000203 NP1238730.RAVvXts0cryHL2ACcONlO8mEnr2D6yEyydY99tBsJpvbU130_provenance.